Everolimus Krka

Everolimus Krka is an oral medication used for various therapeutic purposes. This pharmaceutical is manufactured by Krka, D.D., Novo Mesto, and is designed for oral use.

Everolimus Krka is primarily used to support immune system suppression and to aid in the prevention of organ rejection following transplants. It may also be used in the treatment of certain types of cancer, such as renal cell carcinoma and breast cancer. The medication works by inhibiting the growth of certain cells in the body, which can help to reduce the risk of organ rejection or slow the progression of cancer.

Common effects of Everolimus Krka may include fatigue, nausea, and mouth sores. Some users may also experience swelling in the limbs, high blood sugar, and an increased risk of infection. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Everolimus Krka should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Everolimus Krka may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 system. This includes drugs like ketoconazole, rifampin, and certain antibiotics. Alcohol consumption should also be avoided as it may increase the risk of side effects.